We invite you to join us in meeting with and learning from Rami Levin, President of Sobi North America. Rami will share with us some of the lessons learned in scaling a Swedish biotech company to the United States as well as his thoughts on what has led to Sobi's success. Rami will also highlight how Sobi has incorporated mergers and acquisitions into their business model.
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. obi opened operations in North America in 2014, and have a presence in over 20 countries globally.
Rami Levin is the President of Sobi North America and holds an MBA from Rekanati Business School and BSc in Biology from Tel-Aviv University, Israel. Rami has over 20 years of experience in the pharmaceutical industry in a variety of Marketing, Sales and General Management leadership roles in different countries.
Previous positions: Various senior positions within Merck Serono since 1998, most recently as Vice President of Marketing (US) 2012-2014. Managing Director Scandinavia (Sweden) 2008-2012. Global Marketing Head (Switzerland) 2001-2008. Business Unit Manager (Israel) 1998-2001. Product Manager, Schering AG (Israel) 1996-1998.